Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07535541 · ClinicalTrials.gov registry record · NA
A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)
A NA study, sponsored by University of Virginia.
- Recruiting
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT07535541 is a NA study that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 18 participants.
The verdict
NCT07535541, a NA study, is actively recruiting participants, sponsored by University of Virginia.
- RECRUITING
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if patients with prostate cancer who have vasomotor symptoms, commonly called hot flashes, from their Androgen Deprivation Therapy (ADT) will consistently wear a smartwatch device to track their health data, log hot flashes on their smartwatch, and how these data compare with daily surveys about their hot flashes. Participants will be asked to wear the smartwatch for 4 weeks and to log their hot flashes on their smart watch pressing a button on the watch. Participants will be asked to complete surveys (sent through a text message link) to describe their experiences with hot flashes.
Interventions
- BEHAVIORAL VMS logging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2026-05-21 |
| Est. Completion | 2027-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07535541
The ClinicalTrials.gov registry entry for NCT07535541 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VMS logging is the first listed.
NCT07535541 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07535541 about?
NCT07535541 is a clinical study titled "A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)". The purpose of this study is to find out if patients with prostate cancer who have vasomotor symptoms, commonly called hot flashes, from their Androgen Deprivation Therapy (ADT) will consistently wear a smartwatch device to track their health data, log hot flashes on their smartwatch, and how these ...
What is the current status of trial NCT07535541?
This trial is currently recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2026-05-21. Estimated completion is 2027-05.
What interventions are being tested in trial NCT07535541?
The interventions under investigation include: VMS logging (BEHAVIORAL).
Who is sponsoring clinical trial NCT07535541?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.